Barclays raised the firm’s price target on Cigna (CI) to $305 from $300 and keeps an Overweight rating on the shares. The firm sees managed care stocks benefiting in 2026 from the prospects of margin expansion and rotation away from artificial intelligence-related stocks toward “de-rated underperformers.”
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CI:
- BofA Rolls Out “Top 10 Ideas” for 1Q26 Across Key Sectors
- Buy/Sell: Wall Street’s top 10 stock calls this week
- BofA lays out Top 10 U.S. ideas for Q1
- Trump Trade: Trump strikes deals with nine drugmakers to cut prices
- The Week That Was, The Week Ahead: Macro & Markets, Dec. 20